Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- Africaid Welcomes The Launch Today Of The Foreign Policy Centre's Report - Women And Children First: Leadership And The HIV & AIDS Crisis In Africa
- New Electron Microscopy Images Reveal The Assembly Of HIV
- National AIDS Fund Lauds Initiative To Remove Ban On Federal Funding For Syringe Exchange Programs
- Recent Releases: PEPFAR In Zimbabwe; Dengue In Thailand; Blogs On Improving U.S. Foreign Aid; Examining Allocations Of Health Aid
- Kennedy's Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Illinois FY2010 Budget Keeps Most Funding For HIV/AIDS Services In Tact
- Recent Releases On Global Health
- Proposal Calls For Medicare Coverage Of HIV Screening
- Viewing An HIV Accomplice At An Atomic-Level
- Canadian Court To Determine Constitutionality Of Law Preventing Supervised Drug-Injection Sites
Prescription AIDS Drugs
Contact Us
Longer, Stronger HIV Drug Regimen For Breastfeeding Women Cuts Mother-To-Child Transmission Rate, Study Finds
July 24th, 2009
| Patient / Public: | ![]() |
|
| Health Professional: | ![]() |
|
| Article Opinions: | php?associatednewsid=158547′ rel=’nofollow’>0 posts |
“HIV infection rates among babies are significantly cut when mothers are given prolonged ARV treatment during breastfeeding,” according to findings released at the International AIDS Society conference in Cape Town, South Africa on Wednesday, Reuters reports. According to Reuters, “Key findings from the study showed that a stronger drug cocktail administered over a longer period reduced the risk of mother-to-child HIV transmission compared with the current WHO-recommended short-course ARV regimen.” Tim Farley, project leader for the “Kesho Bora” study - which was conducted at five sites in Burkina Faso, Kenya and South Africa by the WHO in partnership with several other international agencies - said, “The results of this study show an almost two-fold reduction in the risk of HIV transmission during the breastfeeding period and also [show] there is no short-term toxicity (to mothers or infants).” The WHO “is reviewing its 2006 recommendations on the use of ARVs in pregnant women, including during the breastfeeding period. New guidelines are expected to be published by the end of 2009 and will take into account emerging data,” Reuters reports (Roelf, 7/21).
This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
